We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jerry Tan

Jerry K. L. Tan MD, FRCPC

Adjunct Professor, Internal Medicine and Dermatology, Western University, Windsor Campus, Ontario, Canada

Jerry K. L. Tan MD FRCPC is an adjunct professor at the University of Western Ontario, the principal investigator of Windsor Clinical Research Inc., and in private practice in Windsor, Ontario, Canada.  His MD was obtained at Queen’s University; internal medicine residency at the University of Toronto; and dermatology residency at the Universities of British Columbia and Michigan. His research focus is on acne, rosacea, clinical assessment methodology, patient-reported outcomes and medical decision-making. He was awarded a Canadian Dermatology Foundation grant in 2009 for decision-making and on development of decision aids and was the lead investigator for the Canadian Acne Epidemiology Project. He is the chair of the steering committee of the Canadian Acne Clinical Practice Guidelines project. He has served on the organizing committee of the Canadian Institutes of Health Research workshop on skin disease research priorities and is a therapeutic advisor on evidence-based review panels in Canada and the United States. He is a co-recipient of an NIH grant for development and validation of outcome measures in acne. He serves on the editorial board of various dermatology journals and is the chair of scholarship and co-chair of free communications committees, respectively, of the World Congress of Dermatology 2015. He has published more than 70 scientific articles in peer reviewed journals and has presented research findings at national and international meetings.

Disclosures

Dr. Tan's relevant disclosures (for acne) are: Advisor, consultant, speaker and/or clinical trial investigator for Allergan, Cipher, Dermira, Galderma, Roche, Stiefel/GSK, Valeant